Enter at least 4 characters

1 results showing for: 'rurioctocog alfa pegol [recombinant factor viii]'

Rurioctocog alfa pegol [Recombinant factor VIII]    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 42.
[Xpharm]
  • Inj 250 iu vial
    • Brand Fully subsidised brand. Adynovate
    • Pharmacode2561115
    • Subsidy $300.00
    • Measure / Qty per 1
    (Adynovate Inj 250 iu vial to be delisted 01 February 2025)
  • Inj 500 iu vial
    • Brand Fully subsidised brand. Adynovate
    • Pharmacode2561123
    • Subsidy $600.00
    • Measure / Qty per 1
    (Adynovate Inj 500 iu vial to be delisted 01 February 2025)
  • Inj 1,000 iu vial
    • Brand Fully subsidised brand. Adynovate
    • Pharmacode2561131
    • Subsidy $1200.00
    • Measure / Qty per 1
  • Inj 2,000 iu vial
    • Brand Fully subsidised brand. Adynovate
    • Pharmacode2561158
    • Subsidy $2400.00
    • Measure / Qty per 1

For patients with haemophilia A receiving prophylaxis treatment. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management group.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply